Close Menu

NEW YORK (360Dx) – Modest increases in some Medicare clinical lab testing prices for 2018 will take the edge off the final price cuts for laboratory tests stemming from the Protecting Access to Medicare Act in its first year, but will cut more strongly into profits in 2019 and 2020, Quest Diagnostics said on a conference call on Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints. 


As new variants of SARS-CoV-2 circulate around the globe, there is growing concern among clinical laboratories that these variants may impact their ability to accurately detect the virus.